Cequent Pharmaceuticals announced that Harvard Medical School’s Judy Lieberman has joined its scientific advisory board.
Lieberman, well-known for her work in RNAi delivery, is a senior investigator at Harvard’s Immune Disease Institute.She holds a PhD in theoretical physics from Rockefeller Universityand an MD through the Harvard-Massachusetts Institute of Technology program in health, science, and technology.
Cequent also announced that Institut Pasteur professor Patrice Courvalin has also joined its SAB.
Courvalin is the head of the antibacterial agents unit at Institut Pasteur and holds a PhD in medical sciences from the University of Sciences in Paris.